Literature DB >> 18399340

Urinary bladder cancer and schistosomiasis in North-Western Nigeria.

I A Mungadi1, S A Malami.   

Abstract

BACKGROUND: An unusually high prevalence of bladder cancer was noticed by clinicians and in the cancer registry of Usmanu Danfodiyo University Teaching Hospital, Sokoto. Several areas of this region were also known to be endemic for urinary schistosomiasis.
OBJECTIVE: To determine the epidemiological characteristics of bladder cancer in the region and to assess the impact of schistosomiasis on these cases.
METHOD: Retrospective review of clinical and histopathogical records of bladder cancer cases seen at Usmanu Danfodiyo University Teaching Hospital, Sokoto from January 1999 to December 2004. RESULT: One hundred and thirty three cases satisfied our criteria for inclusion. There was a 4.7 fold rise in the number of bladder cancer cases between 1999 and 2004. The male to female ratio was 11.1:1.0. The mean age was 46.0 years and ranged from 20 to 82 years. Majority, 107 (80.5%) were farmers and fishermen from regions of the distribution of surrounding river or their smaller tributaries. Squamous Cell Carcinoma comprised 65.1% of histologically verified cases and in 50% of Squamous Cell Carcinoma; there was histological evidence of chronic urinary schistosomiasis.
CONCLUSION: Bladder cancer is a common malignancy in Sokoto, North-Western Nigeria. The association with chronic urinary schistosomiasis is very strong and the hospital incidence appears to be rising.

Entities:  

Mesh:

Year:  2007        PMID: 18399340     DOI: 10.4314/wajm.v26i3.28315

Source DB:  PubMed          Journal:  West Afr J Med        ISSN: 0189-160X


  8 in total

1.  HISTOPATHOLOGIC PATTERN OF BLADDER CANCERS IN IBADAN SOUTHWEST NIGERIA: AN UPDATE.

Authors:  A O Takure; M O Odubanjo; S A Adebayo; O Oluwasola; O B Shittu; L I Okeke; O A Fadimu; E O Olapade-Olaopa
Journal:  J West Afr Coll Surg       Date:  2015 Apr-Jun

2.  Effects of Toxoplasma gondii and Toxocara canis antigens on WEHI-164 fibrosarcoma growth in a mouse model.

Authors:  Hossein Yousofi Darani; Hedayatollah Shirzad; Fataneh Mansoori; Nozhat Zabardast; Mahdi Mahmoodzadeh
Journal:  Korean J Parasitol       Date:  2009-05-27       Impact factor: 1.341

3.  Current status of schistosomiasis in Sokoto, Nigeria.

Authors:  Kiran Singh; Dalhatu Muddasiru; Jitendra Singh
Journal:  Parasite Epidemiol Control       Date:  2016-08-23

4.  Effectiveness of bladder tumor antigen quantitative test in the diagnosis of bladder carcinoma in a schistosoma endemic area.

Authors:  Abubakar Sadiq Muhammad; Ismaila Arzika Mungadi; Nnaemeka Ndodo Darlington; Garba Diffa Kalayi
Journal:  Urol Ann       Date:  2019 Apr-Jun

5.  Scoping review protocol: bladder cancer in Nigeria: what are the gaps in clinical care and research?

Authors:  Joyce Kibaru; Pinky Kotecha; Abdulkarim Muhammad Iya; Beth Russell; Muzzammil Abdullahi; Sani Usman Alhassan; Muhammad Inuwa Mustapha; Richard T Bryan; Mieke Van Hemelrijck
Journal:  BMJ Open       Date:  2021-01-31       Impact factor: 2.692

Review 6.  Scoping review: bladder cancer in Nigeria - what are the gaps in clinical care and research?

Authors:  Abdulkarim Muhammad Iya; Katharina Beyer; Pinky Kotecha; Joyce Kibaru; Muzzammil Abdullahi; Sani Usman Alhassan; Muhammad Inuwa Mustapha; Abdullahi Ahmad; Yusuf Lawal; Jalo Rabiu Ibrahim; Aliyu Aminu; Aisha Abubakar; Abdullahi Saleh; Richard T Bryan; Mieke Van Hemelrijck; Beth Russell
Journal:  BMJ Open       Date:  2022-03-08       Impact factor: 2.692

7.  Performance of urinary survivin as a non-invasive molecular marker of bladdercarcinoma in a schistosomiasis endemic area.

Authors:  Abubakar S Muhammad; Ismaila A Mungadi; Enemeka D Ndodu; Garba D Kalayi
Journal:  Ghana Med J       Date:  2018-06

8.  Schistosomiasis and urinary bladder cancer in North Western Tanzania: a retrospective review of 185 patients.

Authors:  Peter Fabian Rambau; Philipo L Chalya; Kahima Jackson
Journal:  Infect Agent Cancer       Date:  2013-05-24       Impact factor: 2.965

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.